PharmaDrug: Cepharanthine Identified For Potential To Bind To Monkeypox Proteins In Independent Screening

PharmaDrug (CSE: PHRX) is reporting this morning that cepharanthine, of which their subsidiary has developed a patented version with enhanced oral bioavailability, has been highlighted as having the potential to bind to monkeypox proteins following an independent screening of drugs to treat the disease.

Read more

Sterling Metals Identifies Multiple High Grade Copper Exploration Zones At Copper Road Project

Sterling Metals (TSXV: SAG) has seen its phase one exploration campaign get underway at its recently acquired Copper Road Project in Ontario. The program, although not yet complete, has reportedly resulted in multiple high priority, multi-kilometre copper exploration zones being identified.

Read more

Plurilock Secures Another Sale To United States Department Of Transportation

Plurilock Security (TSXV: PLUR) continues to demonstrate its positive relationship with arms of the United States Government. The company this morning indicated it has entered into another sales agreement with a department of the government, which contains renewal options for up to four years.

Read more

PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial

Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics, to process with a Phase 1 clinical study in Australia. The trial aims to assess a reformulated version of oral cepharanthine, referred to as PD-001, as a treatment for cancer and medical countermeasures.

Read more

Plurilock Files Patent For Generative AI Tech That Prevents Sensitive Data From Being Leaked

Plurilock Security (TSXV: PLUR) has continued to develop security products for use with generative artificial intelligence. The company this morning disclosed that it has filed a nonprovisional patent application with the United States Patent and Trademark Office for its further tech in the category.

Read more

First Majestic Silver Reports Topline Revenues Of $136.2 Million For Second Quarter

First Majestic Silver Corp (TSX: AG) (NYSE: AG) saw a dramatic improvement in topline revenues in the second quarter of 2024, as compared to Q1 2024. The company this morning posted revenues of $136.2 million for the quarter ended June 30, 2024, a 28% increase over the first quarter.

Read more